Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Negative Symptoms in Chronic Schizophrenia
NCT04094207Phase 2Completed
- Sponsor
- Sadat City University
- Start
- Jan 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in schizophrenia, sponsored by Sadat City University. Started Jan 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04094207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094207.